tiprankstipranks
Seelos Therapeutics (SEEL)
NASDAQ:SEEL

Seelos Therapeutics (SEEL) Financial Statements

1,083 Followers

Seelos Therapeutics Financial Overview

Seelos Therapeutics's market cap is currently ―. The company's EPS TTM is $-8.719; its P/E ratio is -0.11; Seelos Therapeutics is scheduled to report earnings on April 26, 2024, and the estimated EPS forecast is $-1.48. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 406.00K$ 336.00K$ 875.00K$ 40.00K$ 0.00
Gross Profit$ 406.00K$ 336.00K$ 875.00K$ 40.00K-
EBIT$ 10.54M$ -29.49M$ -9.19M$ -15.64M$ -19.60M
EBITDA$ 10.55M-$ -9.18M$ -15.59M$ -19.60M
Net Income Common Stockholders$ 10.50M$ -29.50M$ -13.43M$ -18.66M$ -19.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.58M$ 5.80M$ 14.10M$ 15.50M$ 30.51M
Total Assets$ 6.22M$ 11.89M$ 23.68M$ 22.75M$ 40.51M
Total Debt$ 16.91M$ 15.34M$ 16.78M$ 20.12M$ 21.40M
Net Debt$ 14.32M$ 9.54M$ 2.68M$ 4.62M$ -9.11M
Total Liabilities$ 36.63M$ 59.07M$ 44.30M$ 33.36M$ 32.63M
Stockholders Equity$ -30.41M$ -47.18M$ -20.68M$ -10.61M$ 7.88M
Cash Flow-
Free Cash Flow$ -5.75M-$ -10.35M$ -13.09M$ -11.07M
Operating Cash Flow$ -5.75M$ -5.90M$ -10.35M$ -13.09M$ -11.07M
Investing Cash Flow-----
Financing Cash Flow$ 2.49M$ -2.31M$ 8.87M$ -1.89M$ 334.00K
Currency in USD

Seelos Therapeutics Earnings and Revenue History

Seelos Therapeutics Debt to Assets

Seelos Therapeutics Cash Flow

Seelos Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis